Literature DB >> 29181103

Myxoid liposarcoma with cartilaginous differentiation showing DDIT3 rearrangement.

Kayo Suzuki1, Taketoshi Yasuda1, Kenta Watanabe1, Takeshi Hori2, Masahiko Kanamori3, Tomoatsu Kimura1.   

Abstract

Myxoid liposarcoma (MLPS) is the second most common histologic subtype of liposarcoma. However, cartilaginous differentiation within MLPS is an extremely rare phenomenon, with only 7 cases of MLPS with cartilaginous differentiation reported to date. The majority of MLPS cases show the t(12;16)(q13;p11) translocation, resulting in the fused in sarcoma-DNA damage-inducible transcript 3 (FUS-DDIT3) fusion gene. This fusion gene as a hallmark of MLPS is very useful for differential diagnosis from other soft tissue sarcomas, and the associated protein, FUS-DDIT3, performs an important role in the phenotypic selection of targeted multipotent mesenchymal cells during oncogenesis. In this report, a case of MLPS with cartilaginous differentiation that occurred in the thigh of a 44-year-old woman is described. Histopathologically, the tumor was composed of a typical myxoid liposarcoma area and a mature hyaline cartilaginous area. Using fluorescence in situ hybridization analysis, rearrangement of the DDIT3 gene was detected in not only the liposarcomatous area but also in the chondrocytes of the cartilaginous area. Based on these findings, the cartilaginous differentiation area appears to be partially associated with oncogenesis through the specific fusion gene FUS-DDIT3.

Entities:  

Keywords:  DDIT3 rearrangement; MLPS; cartilaginous differentiation; cytogenetics

Year:  2017        PMID: 29181103      PMCID: PMC5696725          DOI: 10.3892/ol.2017.7056

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue.

Authors:  U Yamaguchi; T Hasegawa; Y Morimoto; U Tateishi; M Endo; F Nakatani; A Kawai; H Chuman; Y Beppu; M Endo; H Kurotaki; K Furuta
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

2.  FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells.

Authors:  Rene Rodriguez; Ruth Rubio; Ivan Gutierrez-Aranda; Gustavo J Melen; Carolina Elosua; Javier García-Castro; Pablo Menendez
Journal:  Stem Cells       Date:  2011-02       Impact factor: 6.277

3.  Myxoid liposarcoma with cartilaginous differentiation: a case study with cytogenetical analysis.

Authors:  Hyunchul Kim; Won Hwangbo; Sangjeong Ahn; Suhjin Kim; Insun Kim; Chul Hwan Kim
Journal:  Korean J Pathol       Date:  2013-06-25

4.  Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Hiroatsu Nakashima; Naoki Ishiguro
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

5.  Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma.

Authors:  U Tateishi; T Hasegawa; Y Beppu; A Kawai; N Moriyama
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

6.  Myxoid liposarcoma with cartilaginous differentiation: identification of the same type II TLS-CHOP fusion gene transcript in both lipogenic and chondroid components.

Authors:  Yu-Ching Wei; Chien-Feng Li; Hock-Liew Eng; Ming-Chung Yeh; Ching-Nan Lin; Hsuan-Ying Huang
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-12

7.  Myxoid liposarcoma with cartilaginous differentiation.

Authors:  J D Siebert; R P Williams; D R Pulitzer
Journal:  Mod Pathol       Date:  1996-03       Impact factor: 7.842

Review 8.  Myxoid liposarcoma with cartilaginous differentiation: A case study with fish analysis and review of the literature.

Authors:  Maria G Ioannou; Evangelos Kouvaras; Rodoula Papamichali; Theophilos Karachalios; George Koukoulis
Journal:  Pathol Res Pract       Date:  2013-07-12       Impact factor: 3.250

9.  Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Authors:  Marco Fiore; Federica Grosso; Salvatore Lo Vullo; Elisabetta Pennacchioli; Silvia Stacchiotti; Andrea Ferrari; Paola Collini; Laura Lozza; Luigi Mariani; Paolo G Casali; Alessandro Gronchi
Journal:  Cancer       Date:  2007-06-15       Impact factor: 6.860

10.  Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.

Authors:  Kayo Suzuki; Yoshito Matsui; Mami Higashimoto; Yoshiharu Kawaguchi; Shoji Seki; Hiraku Motomura; Takeshi Hori; Yasuhito Yahara; Masahiko Kanamori; Tomoatsu Kimura
Journal:  PLoS One       Date:  2012-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.